Status | Study |
RECRUITING |
Study Name: Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). Condition: Mitochondrial Diseases Date: 2023-09-12 Interventions: This program teaches the four pillars of resilience (stress management, goal setting, cognitive restructuring, and benefit-finding) in a one-on-one tr |
RECRUITING |
Study Name: The Impact of Mitochondrial Dysfunction on Human Bone Cell Metabolism and Remodelling Condition: Mitochondrial Diseases Date: 2022-07-22 Interventions: Assessment of blood samples, bone marrow and bone biopsy |
Recruiting |
Study Name: An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300) Condition: Primary Mitochondrial Disease Date: 2017-02-03 |
Enrolling by invitation |
Study Name: Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD) Condition: Primary Mitochondrial Disease Date: 2016-11-18 Interventions: Drug: elamipretide 40 mg, subcutaneous injections (in the abdomen) daily for the shortest of the followi |
Recruiting |
Study Name: The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases Condition: Mitochondrial Diseases Date: 2016-06-15 Interventions: Dietary Supplement: Arginine A |
Active, not recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study Condition: Primary Mitochondrial Disease Date: 2016-06-13 Interventions: Drug: Elamipretide 40 mg elami |
Recruiting |
Study Name: GDF-15 as a Biomarker for Mitochondrial Disease Condition: Mitochondrial Disease Metabolic Myopathy Date: 2016-04-12 |
Active, not recruiting |
Study Name: Calf Muscle Strength in Mitochondrial Diseases Condition: Mitochondrial Disease Date: 2016-02-03 Interventions: Other: MRI and muscle dynamometer |
Completed |
Study Name: A Long-Term Extension Study of RP103-MITO-001 (NCT02023866) to Assess RP103 in Children With Inherited Mitochondrial Disease Condition: Mitochondrial Diseases Date: 2015-06-10 Interventions: Drug: Cysteamine Bitartrate Delayed-release Capsules Treatment with experimental drug as detailed in arm |
Recruiting |
Study Name: A Study of Bezafibrate in Mitochondrial Myopathy Condition: Mitochondrial Diseases Date: 2015-03-09 Interventions: Drug: Bezafibrate Bezafibrate 200mg-600mg three times daily for 12 weeks. |